189 related articles for article (PubMed ID: 9038129)
1. 1H T1 and T2 measurements of the MR imaging contrast agents Gd-DTPA and Gd-DTPA BMA at 1.5T.
Reichenbach JR; Hackländer T; Harth T; Hofer M; Rassek M; Mödder U
Eur Radiol; 1997; 7(2):264-74. PubMed ID: 9038129
[TBL] [Abstract][Full Text] [Related]
2. NMRD assessment of Gd-DTPA-bis(methoxyethylamide), (Gd-DTPA-BMEA), a nonionic MRI agent.
Adzamli K; Periasamy MP; Spiller M; Koenig SH
Invest Radiol; 1999 Jun; 34(6):410-4. PubMed ID: 10353033
[TBL] [Abstract][Full Text] [Related]
3. The relaxivity of Gd-EOB-DTPA and Gd-DTPA in liver and kidney of the Wistar rat.
Shuter B; Tofts PS; Wang SC; Pope JM
Magn Reson Imaging; 1996; 14(3):243-53. PubMed ID: 8725190
[TBL] [Abstract][Full Text] [Related]
4. Enhancement effects and relaxivities of gadolinium-DTPA at 1.5 versus 3 Tesla: a phantom study.
Sasaki M; Shibata E; Kanbara Y; Ehara S
Magn Reson Med Sci; 2005; 4(3):145-9. PubMed ID: 16462135
[TBL] [Abstract][Full Text] [Related]
5. Gadolinium-DTPA-enhanced MR imaging of spinal neoplasms: preliminary investigation and comparison with unenhanced spin-echo and STIR sequences.
Stimac GK; Porter BA; Olson DO; Gerlach R; Genton M
AJR Am J Roentgenol; 1988 Dec; 151(6):1185-92. PubMed ID: 3055895
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of two new gadolinium chelates as contrast agents for MRI.
Wiegers CB; Welch MJ; Sharp TL; Brown JJ; Perman WH; Sun Y; Motekaitis RJ; Martell AE
Magn Reson Imaging; 1992; 10(6):903-11. PubMed ID: 1461088
[TBL] [Abstract][Full Text] [Related]
7. Comparison of T1-enhancing and magnetic susceptibility magnetic resonance contrast agents for demarcation of the jeopardy area in experimental myocardial infarction.
Yu KK; Saeed M; Wendland MF; Dae MW; Velasquez-Rocha S; Derugin N; Higgins CB
Invest Radiol; 1993 Nov; 28(11):1015-23. PubMed ID: 7506243
[TBL] [Abstract][Full Text] [Related]
8. Ni-DTPA doped agarose gel--a phantom material for Gd-DTPA enhancement measurements.
Tofts PS; Shuter B; Pope JM
Magn Reson Imaging; 1993; 11(1):125-33. PubMed ID: 8423715
[TBL] [Abstract][Full Text] [Related]
9. Pseudolayering of Gd-DTPA in the urinary bladder.
Elster AD; Sobol WT; Hinson WH
Radiology; 1990 Feb; 174(2):379-81. PubMed ID: 2296649
[TBL] [Abstract][Full Text] [Related]
10. T1 relaxivities of gadolinium-based magnetic resonance contrast agents in human whole blood at 1.5, 3, and 7 T.
Shen Y; Goerner FL; Snyder C; Morelli JN; Hao D; Hu D; Li X; Runge VM
Invest Radiol; 2015 May; 50(5):330-8. PubMed ID: 25658049
[TBL] [Abstract][Full Text] [Related]
11. [Preoperative staging of bladder carcinomas with Gd-DTPA-supported dynamic magnetic resonance tomography. Comparison with plain and Gd-DTPA-supported spin-echo sequences].
Venz S; Hosten N; Ilg J; Mäurer J; Podrabsky P; Fedel M; Ebert T; Nagel R
Rofo; 1996 Mar; 164(3):218-25. PubMed ID: 8672777
[TBL] [Abstract][Full Text] [Related]
12. MR imaging of contrast-enhanced porcine myocardial infarction. Assessment of reperfusion and tissue viability.
Nilsson S
Acta Radiol Suppl; 1995; 397():1-44. PubMed ID: 7484207
[TBL] [Abstract][Full Text] [Related]
13. [High dosage Gd-DPTA-BMA (Gadodiamid) administration in diagnosis and therapeutic monitoring of malignant bone tumors].
Häussler MD; Rummeny EJ; Raufhake C; Blasius S; Lindner N; Daldrup HE; Reimer P; Peters PE
Radiologe; 1996 Feb; 36(2):148-52. PubMed ID: 8867432
[TBL] [Abstract][Full Text] [Related]
14. The measurement of extracellular water volumes in tissues by gadolinium modification of 1H-NMR spin lattice (T1) relaxation.
Braunschweiger PG; Schiffer L; Furmanski P
Magn Reson Imaging; 1986; 4(4):285-91. PubMed ID: 3118123
[TBL] [Abstract][Full Text] [Related]
15. Optimal MR protocol for hepatic hemangiomas. Comparison of conventional spin-echo sequences with T2-weighted turbo spin-echo and serial gradient-echo (FLASH) sequences with gadolinium enhancement.
Kim TK; Choi BI; Han JK; Jang HJ; Han MC
Acta Radiol; 1997 Jul; 38(4 Pt 1):565-71. PubMed ID: 9240679
[TBL] [Abstract][Full Text] [Related]
16. Comparative transmetallation kinetics and thermodynamic stability of gadolinium-DTPA bis-glucosamide and other magnetic resonance imaging contrast media.
Puttagunta NR; Gibby WA; Puttagunta VL
Invest Radiol; 1996 Oct; 31(10):619-24. PubMed ID: 8889650
[TBL] [Abstract][Full Text] [Related]
17. MRI of human tumor xenografts in vivo: proton relaxation times and extracellular tumor volume.
Jakobsen I; Lyng H; Kaalhus O; Rofstad EK
Magn Reson Imaging; 1995; 13(5):693-700. PubMed ID: 8569443
[TBL] [Abstract][Full Text] [Related]
18. T1 and T2 measurements of meningiomas and neuromas before and after Gd-DTPA.
Watabe T; Azuma T
AJNR Am J Neuroradiol; 1989; 10(3):463-70. PubMed ID: 2546413
[TBL] [Abstract][Full Text] [Related]
19. AUR Memorial Award. Identification of myocardial cell death in reperfused myocardial injury using dual mechanisms of contrast-enhanced magnetic resonance imaging.
Geschwind JF; Wendland MF; Saeed M; Lauerma K; Derugin N; Higgins CB
Acad Radiol; 1994 Dec; 1(4):319-25. PubMed ID: 9419506
[TBL] [Abstract][Full Text] [Related]
20. The T2-shortening effect of gadolinium and the optimal conditions for maximizing the CNR for evaluating the biliary system: a phantom study.
Lee MJ; Kim MJ; Yoon CS; Song SY; Park K; Kim WS
Korean J Radiol; 2011; 12(3):358-64. PubMed ID: 21603295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
